|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 269.5 AUD | -0.70% |
|
-4.33% | -5.99% |
| Apr. 19 | Vifor Pharma offers to rectify anti-competitive behaviour against rival | RE |
| Apr. 10 | Miners boost Australian shares; NZ cenbank keeps rates steady | RE |
Dec 14 (Reuters) - Australian biopharmaceutical giant CSL Ltd on Tuesday applied for a trading halt in its shares ahead of an expected deal to buy Swiss drugmaker Vifor Pharma AG .
CSL had confirmed it was in talks to buy Vifor on Monday. Australian media have reported the deal could be worth $12 billion. (Reporting by Shashwat Awasthi in Bengaluru; Editing by Ramakrishnan M.)
| 1st Jan change | Capi. | |
|---|---|---|
| -5.99% | 84.46B | |
| +2.76% | 40.85B | |
| -24.88% | 27.69B | |
| +53.61% | 24.28B | |
| -8.08% | 17.09B | |
| -33.74% | 13.67B | |
| -16.63% | 11.86B | |
| -11.19% | 11.79B | |
| -2.25% | 8.07B | |
| +1.05% | 7.51B |
CSL LIMITED 
